In the present meta-analysis, we synthesized all the published studies that examined the performance characteristics of one tubular biomarker, the urinary biomarker KIM-1 and one inflammatory marker, the serum/plasma YKL-40 biomarker in order to evaluate their performance in the prediction of early DN in T2DM patients. This evidence concerns the gene CHI3L1 and type 2 diabetes mellitus.